BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma (Q34699520)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma |
scientific article |
Statements
1 reference
BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma (English)
1 reference
Ali Fendri
1 reference
Abdelmajid Khabir
1 reference
Raja Mokdad-Gargouri
1 reference
8 December 2010
1 reference
1 reference
17
1 reference
3-4
1 reference
163-171
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference